P/E ratio for Medistim (MEDI.OL)
P/E ratio as of March 2025 (TTM): 29.4
According to Medistim's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 29.3644. At the end of 2023 the company had a P/E ratio of 37.7.
P/E ratio history for Medistim from 2010 to 2024
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2023 | 37.7 | 1.94% |
| 2022 | 37.0 | -49.81% |
| 2021 | 73.6 | 12.24% |
| 2020 | 65.6 | 32.26% |
| 2019 | 49.6 | 133.21% |
| 2018 | 21.3 | -22.59% |
| 2017 | 27.5 | -19.61% |
| 2016 | 34.2 | 41.83% |
| 2015 | 24.1 | 51.63% |
| 2014 | 15.9 | 1.6% |
| 2013 | 15.6 | 29.86% |
| 2012 | 12.0 | -48.8% |
| 2011 | 23.5 | -4% |
| 2010 | 24.5 | 64.49% |
| 2009 | 14.9 | -31.37% |
| 2008 | 21.7 | 81.12% |
| 2007 | 12.0 | -31.81% |
| 2006 | 17.6 | -12.11% |
| 2005 | 20.0 | 3.3% |
| 2004 | 19.4 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.